Security Snapshot

PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) Institutional Ownership

CUSIP: 74449F209

13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.44

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
4,527,832
SEC-reported price per share
$0.44
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value is tracked under CUSIP 74449F209.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
  • SEC-reported value moved from $462,000 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

74449F209

Latest holder period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
PBM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Psyence Group Inc. 15% $380,084 678,722 Psyence Group Inc. 25 Mar 2025
Hudson Bay Capital Management LP 5% -50% $133,150 -$79,650 237,768 -37% Hudson Bay Capital Management LP 31 Mar 2025
AdvisorShares Trust 0.79% $15,077 26,924 AdvisorShares Trust 31 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
4
Latest
n/a
Rows shown
1-4 of 4
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$462,000 $0.44 0
2025 Q2 275,000 $462,000 +$189,166 $1.68 1
2025 Q1 455,006 $272,834 -$1,162,584 $0.60 8
2024 Q4 749,870 $1,532,176 +$1,147,474 $2.11 11
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .